Article
Virally Mediated Overexpression of Glial-Derived Neurotrophic Factor Elicits Age- and Dose-Dependent Neuronal Toxicity and Hearing Loss.
Human gene therapy - 1 Jan 2019
Akil Omar, Blits Bas, Lustig Lawrence R, Leake Patricia A
Abstract excerpt
Contemporary cochlear implants (CI) are generally very effective for remediation of severe to profound sensorineural hearing loss, but outcomes are still highly variable. Auditory nerve survival is likely one of the major factors underlying this variability. Neurotrophin therapy therefore has been proposed for CI recipients, with the goal of improving outcomes by promoting improved survival of cochlear spiral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
